Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.7620
-0.0270 (-3.42%)
At close: Aug 1, 2025, 4:00 PM
0.7500
-0.0120 (-1.57%)
After-hours: Aug 1, 2025, 7:54 PM EDT

Company Description

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies.

It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples.

This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.

The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019.

Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

Predictive Oncology Inc.
Predictive Oncology logo
CountryUnited States
Founded2002
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees24
CEORaymond Vennare

Contact Details

Address:
91 43rd Street, Suite 110
Pittsburgh, Pennsylvania 15201
United States
Phone412 432 1500
Websitepredictive-oncology.com

Stock Details

Ticker SymbolPOAI
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001446159
CUSIP Number74039M200
ISIN NumberUS74039M3097
Employer ID33-1007393
SIC Code3842

Key Executives

NamePosition
Raymond F. VennareChief Executive Officer and Chairman
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.Senior Vice President of Biologics
Dr. Arlette H. Uihlein FCAP, M.D.Senior Vice President of Translational Medicine and Drug Discovery and Medical Director

Latest SEC Filings

DateTypeTitle
Jul 29, 2025424B3Prospectus
Jul 28, 2025EFFECTNotice of Effectiveness
Jul 24, 20258-KCurrent Report
Jul 18, 2025S-1General form for registration of securities under the Securities Act of 1933
Jul 18, 20258-KCurrent Report
Jul 11, 20258-KCurrent Report
Jul 8, 20258-KCurrent Report
Jun 11, 20258-KCurrent Report
Jun 6, 20258-KCurrent Report
Jun 2, 2025424B5Filing